Search - tctmd.com

Displaying 1 - 20 of 426

Sort: Relevancy | Date

Presentation EuroPCR 2025

Surgical versus percutaneous treatment of bicuspid aortic stenosis: a propensity score analysis

Presenter: Pierre Deharo

May 22, 2025

Presentation Miami Valves 2025

TAVR Failures: Complex Decision Making for Aortic Stenosis Management

Presenter: Jeffrey Popma

January 30, 2025

Presentation TCT 2024

TCT 654: Treatment Patterns for Severe Aortic Stenosis in a Large Community-based Health Care System

Presenter: Daniel Spoon

October 30, 2024

Presentation TCT 2024

The Rise of AHA Target: Aortic Stenosis – Applying Quality Improvement Upstream of the Procedure (in partnership with the American Heart Association)

Presenter: Brian Lindman

October 30, 2024

Presentation TCT 2024

TCT 861: CURE-VHD (Comprehensive Unified Regimen for Eliminating Valvular Heart Disease): Using Artificial Intelligence to Identify Patients With Untreated Aortic Stenosis

Presenter: Daniel Mitchell

October 30, 2024

Presentation TCT 2024

TCT 854: Physiologic Response of Normal Aortic Valves During Dobutamine Stress

Presenter: Rob Eerdekens

October 30, 2024

Presentation TCT 2024

TCT 655: Hemodynamic Effects of Aortic Banding to Simulate Progressive Aortic Stenosis

Presenter: Rob Eerdekens

October 30, 2024

Presentation TCT 2024

TCT 653: Transcatheter or Surgical Aortic Valve Replacement Versus Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

Presenter: Philippe Genereux

October 30, 2024

Presentation TCT 2024

TCT 651: Clinical Presentation Before Aortic Valve Replacement for Aortic Stenosis

Presenter: Philippe Genereux

October 30, 2024

Presentation TCT 2024

TCT 650: Independent Predictors of 2-Year Mortality in Patients With Paradoxical Low-Flow, Low-Gradient Aortic Stenosis Treated With Transcatheter Aortic Valve Replacement

Presenter: Vincent Lipari

October 30, 2024

Presentation TCT 2024

TCT 649: Mortality Is Lowest in Overweight Followed by Obese and Morbid Obese Patients and Is Highest in Cachexia Compared to Normal Weight in Patients With a Diagnosis of Aortic Stenosis

Presenter: Mohammad Reza Movahed

October 30, 2024

Presentation TCT 2024

TCT 648: HFpEF Phenotype Is Associated With Early Symptom-Onset in Aortic Stenosis and Residual Symptomatic Burden After Transcatheter Aortic Valve Replacement

Presenter: Constantijn Venema

October 30, 2024

Presentation TCT 2024

TCT 647: A Novel Functional Index - Aortic Valve Coefficient (AVC) - For Assessing Low Flow-Low Gradient Aortic Valve Stenosis: A Prospective Study in Patients Undergoing TAVR

Presenter: Rishi Sukhija

October 30, 2024

Presentation TCT 2024

TCT 646: The Aortic Valve Coefficient (AVC) Cut-off Values for Improved Assessment of Aortic Stenosis Severity: A Prospective Study

Presenter: Rupak Banerjee

October 30, 2024

Presentation TCT 2024

TCT 645: Calcified Aortic Valve Disease-related Mortality Trends in the United States Over the Past 3 Decades

Presenter: Zaid Abdulelah

October 30, 2024

Presentation TCT 2024

The Impact of Access Disparities on Appropriate AS Therapy and Clinical Outcomes

Presenter: David Wood

October 30, 2024

Presentation TCT 2024

Impact of Delays in Diagnosis and Treatment: Join the AHA TARGET AS Program!

Presenter: Brian Lindman

October 30, 2024

Presentation TCT 2024

Can AI-Assisted Earlier AS Diagnosis Level the Disparities Playing Field?

Presenter: Pierre Elias

October 30, 2024

Presentation TCT 2024

TCT 799: Unveiling Demographic Disparities in Aortic Stenosis Mortality: An Analysis of Trends and Data Gaps in the United States

Presenter: Mobeen Haider

October 30, 2024

Presentation TCT 2024

The Emerging Use of TAVR in Younger Patients: Updates and Evidence Gaps

Presenter: Harold Dauerman

October 30, 2024

Advertisement

Surgical versus percutaneous treatment of bicuspid aortic stenosis: a propensity score analysis

TAVR Failures: Complex Decision Making for Aortic Stenosis Management

TCT 654: Treatment Patterns for Severe Aortic Stenosis in a Large Community-based Health Care System

The Rise of AHA Target: Aortic Stenosis – Applying Quality Improvement Upstream of the Procedure (in partnership with the American Heart Association)

TCT 861: CURE-VHD (Comprehensive Unified Regimen for Eliminating Valvular Heart Disease): Using Artificial Intelligence to Identify Patients With Untreated Aortic Stenosis

TCT 854: Physiologic Response of Normal Aortic Valves During Dobutamine Stress

TCT 655: Hemodynamic Effects of Aortic Banding to Simulate Progressive Aortic Stenosis

TCT 653: Transcatheter or Surgical Aortic Valve Replacement Versus Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

TCT 651: Clinical Presentation Before Aortic Valve Replacement for Aortic Stenosis

TCT 650: Independent Predictors of 2-Year Mortality in Patients With Paradoxical Low-Flow, Low-Gradient Aortic Stenosis Treated With Transcatheter Aortic Valve Replacement

TCT 649: Mortality Is Lowest in Overweight Followed by Obese and Morbid Obese Patients and Is Highest in Cachexia Compared to Normal Weight in Patients With a Diagnosis of Aortic Stenosis

TCT 648: HFpEF Phenotype Is Associated With Early Symptom-Onset in Aortic Stenosis and Residual Symptomatic Burden After Transcatheter Aortic Valve Replacement

TCT 647: A Novel Functional Index - Aortic Valve Coefficient (AVC) - For Assessing Low Flow-Low Gradient Aortic Valve Stenosis: A Prospective Study in Patients Undergoing TAVR

TCT 646: The Aortic Valve Coefficient (AVC) Cut-off Values for Improved Assessment of Aortic Stenosis Severity: A Prospective Study

TCT 645: Calcified Aortic Valve Disease-related Mortality Trends in the United States Over the Past 3 Decades

The Impact of Access Disparities on Appropriate AS Therapy and Clinical Outcomes

Impact of Delays in Diagnosis and Treatment: Join the AHA TARGET AS Program!

Can AI-Assisted Earlier AS Diagnosis Level the Disparities Playing Field?

TCT 799: Unveiling Demographic Disparities in Aortic Stenosis Mortality: An Analysis of Trends and Data Gaps in the United States

The Emerging Use of TAVR in Younger Patients: Updates and Evidence Gaps

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content